Education
About Us
Working with TipRanks
Follow Us
Interpace Diagnostics Group Inc. (IDXG)
:IDXG
RESEARCH TOOLSreports
Total Valuation
Interpace Diagnostics Group has a market cap or net worth of $4.60M. The enterprise value is $16.29M.
Market Cap$4.60M
Enterprise Value$16.29M
Share Statistics
Interpace Diagnostics Group has 4,423,093 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,423,093
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Interpace Diagnostics Group’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is 269.70%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)269.70%
Return on Capital Employed (ROCE)-0.63
Revenue Per Employee362.29K
Profits Per Employee7.23K
Employee Count111
Asset Turnover3.09
Inventory Turnover13.29
Valuation Ratios
The current PE Ratio of Interpace Diagnostics Group is 5.81. Interpace Diagnostics Group’s PEG ratio is -0.05.
PE Ratio5.81
PS Ratio0.12
PB Ratio-0.31
Price to Fair Value-0.31
Price to FCF1.40
Price to Operating Cash Flow1.23
PEG Ratio-0.05
Income Statement
In the last 12 months, Interpace Diagnostics Group had revenue of 40.21M and earned 802.00K in profits. Earnings per share was 0.19.
Revenue40.21M
Gross Profit23.90M
Operating Income2.80M
Pretax Income1.13M
Net Income802.00K
EBITDA3.84M
Earnings Per Share (EPS)0.19
Cash Flow
In the last 12 months, operating cash flow was 4.60M and capital expenditures -889.00K, giving a free cash flow of 3.71M billion.
Operating Cash Flow4.60M
Free Cash Flow3.71M
Free Cash Flow per Share0.84
Dividends & Yields
Interpace Diagnostics Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.69
52-Week Price Change-35.48%
50-Day Moving Average1.16
200-Day Moving Average1.75
Relative Strength Index (RSI)43.56
Average Volume (3m)4.66K
Important Dates
Interpace Diagnostics Group upcoming earnings date is May 19, 2025, TBA Not Confirmed.
Last Earnings DateMar 26, 2025
Next Earnings DateMay 19, 2025
Ex-Dividend Date―
Financial Position
Interpace Diagnostics Group as a current ratio of 0.59, with Debt / Equity ratio of -10.67%
Current Ratio0.59
Quick Ratio0.52
Debt to Market Cap2.00
Net Debt to EBITDA2.01
Interest Coverage Ratio2.78
Taxes
In the past 12 months, Interpace Diagnostics Group has paid 17.00K in taxes.
Income Tax17.00K
Effective Tax Rate0.02
Enterprise Valuation
Interpace Diagnostics Group EV to EBITDA ratio is 3.22, with an EV/FCF ratio of 3.72.
EV to Sales0.31
EV to EBITDA3.22
EV to Free Cash Flow3.72
EV to Operating Cash Flow3.26
Balance Sheet
Interpace Diagnostics Group has $2.11M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$924.00K billion.
Cash & Marketable Securities$2.11M
Total Debt$0.00
Net Cash-$924.00K
Net Cash Per Share-$0.21
Tangible Book Value Per Share-$3.51
Margins
Gross margin is 60.40%, with operating margin of 6.97%, and net profit margin of 1.99%.
Gross Margin60.40%
Operating Margin6.97%
Pretax Margin2.81%
Net Profit Margin1.99%
EBITDA Margin9.54%
EBIT Margin6.99%
Analyst Forecast
The average price target for Interpace Diagnostics Group is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast16.93%
EPS Growth Forecast543.09%